UBS upgrades Scotts Miracle-Gro stock rating on valuation
UBS upgraded Scotts Miracle-Gro (SMG) to Buy with a $70 price target, down from $78, citing 40% upside potential. The stock has fallen 25.7% since August, trading near 52-week lows. UBS sees earnings growth through 2027, driven by revenue growth and productivity initiatives. SMG reported Q3 2026 earnings of $2.82 per share, beating estimates, and raised its full-year EPS outlook.
How this was made
The 30-second read
Why it matters
The upgrade provides a fresh catalyst that could trigger a short‑term rally.
Market read
Analyst upgrade with a new price target is a primary market‑moving event for SMG.
What to watch
Potential downside from consumer‑confidence weakness and higher input costs.
Background
UBS highlighted SMG's low valuation relative to October 2023 lows and projected organic revenue growth.
Ticker impact
UBS upgraded Scotts Miracle‑Gro to Buy with a new $70 price target, citing valuation upside.
upward pressure as the market absorbs the higher target and buy rating
Analyst upgrade with a 40% upside thesis provides a clear catalyst for buying interest.
Market effects
The upgrade may boost sentiment in the consumer‑goods and lawn‑care sector.
US investors may increase exposure to SMG, modestly affecting broader market breadth.
Limited to US equities; no direct global ripple.
Counterpoint
Some investors may view the upgrade as premature given lingering inflationary pressures.
Key entities
- analystUBS
Equity research firm issuing the upgrade.
- companyScotts Miracle‑Gro
US‑listed lawn‑care and garden products company.
